The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A von Valke, Lars L.F.G., Verhagen, Marieke J.A., Mulders, Bart T.P.M., Polenewen, Robert, Blijlevens, Nicole M.A., Jansen, Joop H., Mansouritorghabeh, Hassan, Elsheikh, Einas, Reipert, Birgit M., Turecek, Peter L., O'Donnell, James S., Rijpma, Sanna R., Schols, Saskia E.M., van Heerde, Waander L., Meijer, Danielle

Volltext